280 related articles for article (PubMed ID: 31803175)
21. Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy.
Minami Y; Nishida N; Kudo M
Eur Radiol; 2019 Sep; 29(9):5045-5051. PubMed ID: 30963271
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases.
van Duijnhoven FH; Jansen MC; Junggeburt JM; van Hillegersberg R; Rijken AM; van Coevorden F; van der Sijp JR; van Gulik TM; Slooter GD; Klaase JM; Putter H; Tollenaar RA
Ann Surg Oncol; 2006 May; 13(5):651-8. PubMed ID: 16538411
[TBL] [Abstract][Full Text] [Related]
23. Clinical scenarios associated with local recurrence after laparoscopic radiofrequency thermal ablation of colorectal liver metastases.
Aksoy E; Aliyev S; Taskin HE; Birsen O; Mitchell J; Siperstein A; Berber E
Surgery; 2013 Oct; 154(4):748-52; discussion 752-4. PubMed ID: 24074411
[TBL] [Abstract][Full Text] [Related]
24. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.
Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I
Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357
[TBL] [Abstract][Full Text] [Related]
25. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases.
He N; Jin QN; Wang D; Yang YM; Liu YL; Wang GB; Tao KX
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):514-518. PubMed ID: 27465325
[TBL] [Abstract][Full Text] [Related]
26. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.
Gleisner AL; Choti MA; Assumpcao L; Nathan H; Schulick RD; Pawlik TM
Arch Surg; 2008 Dec; 143(12):1204-12. PubMed ID: 19075173
[TBL] [Abstract][Full Text] [Related]
27. Profile of serum factors and disseminated tumor cells before and after radiofrequency ablation compared to resection of colorectal liver metastases - a pilot study.
Hinz S; Tepel J; Röder C; Kalthoff H; Becker T
Anticancer Res; 2015 May; 35(5):2961-7. PubMed ID: 25964582
[TBL] [Abstract][Full Text] [Related]
28. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
29. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
Marcu A; Bichmann L; Kuchenbecker L; Kowalewski DJ; Freudenmann LK; Backert L; Mühlenbruch L; Szolek A; Lübke M; Wagner P; Engler T; Matovina S; Wang J; Hauri-Hohl M; Martin R; Kapolou K; Walz JS; Velz J; Moch H; Regli L; Silginer M; Weller M; Löffler MW; Erhard F; Schlosser A; Kohlbacher O; Stevanović S; Rammensee HG; Neidert MC
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858848
[TBL] [Abstract][Full Text] [Related]
30. Thermal Radiofrequency Ablation as an Adjuvant Therapy for Patients With Colorectal Liver Metastasis.
Fan Y; Zhu X; Lan Q; Lou F; Zheng Y; Lou H; Fang Y; Jin W; Pan H; Wang K
Oncol Res; 2016; 23(5):219-28. PubMed ID: 27098145
[TBL] [Abstract][Full Text] [Related]
31. Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy.
Fan XX; Lv SY; Zhang MW; Dai XY; Zhao JP; Mao DF; Zhang Y
World J Surg Oncol; 2020 Apr; 18(1):76. PubMed ID: 32312256
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
[TBL] [Abstract][Full Text] [Related]
33. Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon.
Nijkamp MW; van der Bilt JD; de Bruijn MT; Molenaar IQ; Voest EE; van Diest PJ; Kranenburg O; Borel Rinkes IH
Ann Surg; 2009 May; 249(5):814-23. PubMed ID: 19387320
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of radiofrequency ablation with aflibercept and FOLFIRI in a patient with metastatic colorectal cancer.
Agarwal A; Daly KP; Butler-Bowen H; Saif MW
Anticancer Res; 2014 Nov; 34(11):6775-8. PubMed ID: 25368290
[TBL] [Abstract][Full Text] [Related]
35. Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of Tumors.
Masuda T; Margonis GA; Andreatos N; Wang J; Warner S; Mirza MB; Angelou A; Damaskos C; Garmpis N; Sasaki K; He J; Imai K; Yamashita YI; Wolfgang CL; Baba H; Weiss MJ
Anticancer Res; 2018 Nov; 38(11):6353-6360. PubMed ID: 30396957
[TBL] [Abstract][Full Text] [Related]
36. [Radiofrequency ablation of colorectal liver metastases].
Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
[TBL] [Abstract][Full Text] [Related]
37. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases.
Eltawil KM; Boame N; Mimeault R; Shabana W; Balaa FK; Jonker DJ; Asmis TR; Martel G
J Surg Oncol; 2014 Nov; 110(6):734-8. PubMed ID: 24965163
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis.
Aliyev S; Agcaoglu O; Aksoy E; Taskin HE; Vogt D; Fung J; Siperstein A; Berber E
Surgery; 2013 Sep; 154(3):556-62. PubMed ID: 23859307
[TBL] [Abstract][Full Text] [Related]
39. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
40. Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.
Löffler MW; Kowalewski DJ; Backert L; Bernhardt J; Adam P; Schuster H; Dengler F; Backes D; Kopp HG; Beckert S; Wagner S; Königsrainer I; Kohlbacher O; Kanz L; Königsrainer A; Rammensee HG; Stevanović S; Haen SP
Cancer Res; 2018 Aug; 78(16):4627-4641. PubMed ID: 29789417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
